Paraquat Settlement Amounts: There Is No Settlement Yet — Here's What's Actually True
If you searched for "paraquat settlement amounts," the honest answer is that no global settlement has been reached. Syngenta's paraquat litigation is consolidated as MDL 3004 in the Southern District of Illinois, where 6,655 cases are pending as of August 2026. Bellwether trials and case selection are underway, but no settlement fund, payout schedule or claim form exists. This page explains where the litigation actually stands, what has happened so far, and why a widely repeated dollar estimate you may have seen is not a settlement figure at all.
Editorially Reviewed — Content reviewed for accuracy using published legal research, government data, and verified court records. See our methodology
Reviewed by Leonard Goldberg, Editor · Last updated
What the Paraquat Lawsuits Allege
The lawsuits consolidated in MDL 3004 allege that long-term exposure to paraquat, a herbicide manufactured by Syngenta and widely used in commercial agriculture, is linked to Parkinson's disease, and that Syngenta failed to adequately warn users of that risk. Plaintiffs typically describe exposure through mixing, loading, or applying the herbicide, or through working in fields where it was used, over years or decades, followed by a later Parkinson's diagnosis. As of August 2026, 6,655 cases are pending in the multidistrict litigation, up from 6,470 in December 2025 — a steady rise rather than a sudden spike. The litigation has been building toward a series of bellwether trials — individual test cases used to gauge how juries respond to the evidence — rather than a global resolution, and that remains true today.
Case Details
In re: Paraquat Products Liability Litigation, MDL No. 3004, United States District Court for the Southern District of Illinois. A separate bellwether case has also proceeded through a Pennsylvania state court in Philadelphia. No settlement has been reached in either forum.
Where the Litigation Stands Today
No global settlement exists. As of the most recent confirmed status, in March 2026, no company-wide paraquat settlement had been announced, and bellwether trials and case selection were continuing on their own track. Nothing since then changes that basic fact: there is no settlement fund, no claims administrator, no payout schedule, and no claim form to file for a paraquat case.
What has happened is narrower. In January 2026, Syngenta resolved one individual case that had been scheduled to go to trial before the end of that month, and the broader MDL's pretrial schedule was extended into March. Separately, the first bellwether trial moved forward on 26 January 2026 in a Philadelphia state court — a single case tried to verdict, not a settlement covering other claimants.
In March 2026, Syngenta announced it would end production of paraquat. That is a business decision about the product going forward; it is not an admission tied to a settlement and it does not by itself create any fund for people already exposed. In May 2026, Vermont's legislature moved toward becoming the first U.S. state to ban the sale and use of paraquat, following a state Senate vote — a regulatory development, again separate from the litigation's settlement status.
Individual settlements of single cases, like the one in January 2026, happen from time to time in mass litigation and don't set a template for everyone else. They are not a global settlement, and they don't tell you what a broader resolution — if one is eventually reached — would look like. In practice, mass tort litigation like this often moves toward resolution only after a run of bellwether trial verdicts gives both sides a clearer sense of how a jury is likely to value these claims — which is part of why the case count and bellwether calendar matter more right now than any dollar figure being floated online.
Who the Paraquat Litigation Involves
The lawsuits in MDL 3004 generally involve people who were exposed to paraquat — most often through agricultural or occupational use — and who were later diagnosed with Parkinson's disease. Because there is no settlement and no claims process open, there is no published eligibility checklist to compare yourself against; eligibility for an eventual settlement, if one happens, would be defined by whatever agreement is reached and by the individual facts of exposure and diagnosis a claimant can document.
What's reasonable to do while the litigation continues:
- Keep records of paraquat exposure. Employment history, purchase or application records, and any documentation connecting you to the product matter regardless of when or whether a settlement happens.
- Keep medical records of a Parkinson's diagnosis current and organized, including the date of diagnosis and treating physicians.
- Track the litigation's progress rather than a specific date. Bellwether trial outcomes, not a calendar deadline, are usually what moves mass litigation like this toward a global settlement — there is no fixed date to watch for.
- Be skeptical of anyone telling you a paraquat settlement is open now. As of this writing, it is not, and no legitimate settlement process would need to pressure you to act before terms are even published.
About the "$100,000 to $150,000" Figure You May Have Seen
You may have come across a figure suggesting paraquat settlements could average $100,000 to $150,000. It's worth being precise about what that number actually is: legal commentators have offered that estimate, and they have arrived at it by drawing a comparison to what Bayer/Monsanto has paid out in Roundup litigation — a different case, involving a different product and a different set of settlements. It is not a number that comes from any paraquat settlement, because no paraquat settlement exists to produce one.
Treat that figure as a third party's guess about a future that hasn't happened, not as a projection you can rely on. Even in litigation where a settlement does exist, individual payouts vary enormously based on the strength of a person's exposure evidence, diagnosis, age, and other case-specific facts — and any published range is typically reduced by attorney's fees and other case costs before it reaches a claimant. None of that math can be run for paraquat yet, because there is no settlement structure to run it against.
If and when Syngenta and plaintiffs' counsel reach a global resolution — through further bellwether results, mediation, or another path — the actual terms, eligibility criteria and payout structure will be published by the court or by a claims administrator. Until that happens, any specific dollar figure attached to "paraquat settlement" is, at best, informed speculation.
How the Paraquat Litigation Has Developed
- 1
December 2025 — 6,470 cases pending
MDL 3004 in the Southern District of Illinois reaches 6,470 pending paraquat cases as bellwether preparation continues.
- 2
January 2026 — an individual case settles
Syngenta resolves one case that had been scheduled to go to trial before the end of the month. The broader MDL pretrial schedule is extended into March. This is a single-case resolution, not a global settlement.
- 3
26 January 2026 — first bellwether trial begins
A bellwether paraquat case proceeds to trial in a Pennsylvania state court in Philadelphia, separate from the federal MDL. Bellwether trials are used to test how juries respond to the evidence, not to resolve other claimants' cases.
- 4
March 2026 — no global settlement confirmed
As of this point, no company-wide paraquat settlement has been announced. Bellwether proceedings and case selection continue in MDL 3004.
- 5
March 2026 — Syngenta announces the end of paraquat production
Syngenta states it will stop producing paraquat. This is a forward-looking business decision about the product, separate from — and not an admission tied to — any litigation settlement.
- 6
May 2026 — Vermont moves toward a state ban
Following a state Senate vote, Vermont moves toward becoming the first U.S. state to ban the sale and use of paraquat. This is a regulatory development, distinct from the status of the MDL litigation.
- 7
August 2026 — 6,655 cases pending, no settlement
MDL 3004 now includes 6,655 pending cases, up from 6,470 in December 2025. Bellwether trials and case selection continue. There is still no global settlement, no settlement fund, and no claim form.
What to Be Careful About
Heavy search interest in "paraquat settlement amounts" is exactly the kind of demand that draws people offering to sign you up for a settlement that doesn't exist. These are the patterns to watch for specifically here.
"File your paraquat settlement claim now"
There is no paraquat settlement to file a claim with. MDL 3004 has not reached a global resolution, and no claims administrator, claim form or deadline exists for paraquat cases as a whole. If someone is offering to submit a settlement claim for you today, they are describing a process that hasn't opened.
Quoting the $100,000-$150,000 estimate as a guaranteed payout
The $100,000 to $150,000 figure circulating online is an estimate from legal commentators, based on a comparison to Roundup settlement payouts — not a number drawn from any actual paraquat settlement. Advertising or calls that present it as what you'll receive, or as a guaranteed range, are treating a third party's guess as a fact that doesn't yet exist.
Urgency built around a settlement fund running out
Because there is no settlement fund, there is nothing for a paraquat case to "run out." Pressure tactics that invoke a shrinking pool of money, a closing window, or a limited number of settlement slots for paraquat specifically are describing a structure that doesn't exist at this stage of the litigation.
Common Questions
Is there a paraquat settlement I can file a claim for?
No. As of August 2026, MDL 3004 has not reached a global settlement. There are 6,655 pending cases, bellwether trials and case selection are ongoing, but no settlement fund, claims administrator, claim form or deadline exists for paraquat cases generally.
I've seen paraquat settlements estimated at $100,000 to $150,000 — is that accurate?
That figure is an estimate offered by legal commentators, derived from comparing paraquat litigation to what Bayer/Monsanto has paid in Roundup settlements. It does not come from any actual paraquat settlement, because no paraquat settlement has been reached. Treat it as a third-party projection about a future that hasn't happened, not as a number you can rely on.
What happened with the paraquat case that settled in January 2026?
Syngenta resolved a single individual case that had been scheduled to go to trial before the end of January 2026. That resolved one plaintiff's claim; it is not a global settlement and doesn't set payout terms for other paraquat cases.
What was the first paraquat bellwether trial?
The first bellwether paraquat trial began on 26 January 2026 in a Pennsylvania state court in Philadelphia. Bellwether trials are test cases used to see how juries respond to the evidence in a set of representative claims; the outcome of one bellwether trial does not resolve other pending cases.
Does Syngenta ending paraquat production mean a settlement is coming?
Not necessarily. In March 2026, Syngenta announced it would stop producing paraquat, a decision about the product's future rather than an admission connected to any settlement. Companies sometimes discontinue a product for regulatory, commercial or reputational reasons that have nothing to do with resolving pending litigation. It does not, by itself, create a settlement fund or change the status of pending litigation.
How many paraquat lawsuits are currently pending?
As of August 2026, 6,655 cases are pending in MDL 3004, the federal paraquat multidistrict litigation in the Southern District of Illinois — up from 6,470 cases in December 2025.
Does Vermont's move to ban paraquat affect existing lawsuits?
Vermont's state Senate vote in May 2026, moving toward becoming the first state to ban the sale and use of paraquat, is a regulatory development separate from MDL 3004. It doesn't change the settlement status of pending federal or state lawsuits.
What should someone with a possible paraquat exposure and Parkinson's diagnosis do right now?
Preserve documentation of paraquat exposure — employment history, application or purchase records — along with medical records establishing a Parkinson's diagnosis. There is no settlement claim to file today, but that evidence is what any future claim, whether through a settlement or an individual lawsuit, would depend on.
Separate from this case: were you injured in the last 2 years?
Class-action payouts are fixed amounts through an administrator. A personal injury claim is a different case — and often worth far more. Free estimate, no obligation.